Status:
COMPLETED
Magnesium and Vanadium Levels in Preeclampsia
Lead Sponsor:
Cengiz Gokcek Women's and Children's Hospital
Conditions:
Preeclampsia
Eligibility:
FEMALE
18-40 years
Brief Summary
Introduction: Vanadium important pollutants produced from anthropogenic activities, has been suggested to be embryotoxic and fetotoxic in a lot of studies. Magnesium sulfate therapy is used very commo...
Detailed Description
This observational case-control study will be conducted at the Department of Obstetrics and Gynecology, Cengiz Gokcek Public Hospital, Gaziantep, Turkey, between May 2020 and February 2021. The protoc...
Eligibility Criteria
Inclusion
- preeclampsia
- healthy pregnancy
- healthy women
Exclusion
- pregnant women with any systemic condition (such as chronic hypertension, renal disease and diabetes mellitus)
- using any kind of medication/supplement intake throughout pregnancy (such as heparin)
- history of medication for PE treatment at the time of first admission
- smoking
- drug user
- patients who had fetal congenital abnormalities or genetic syndromes
- multiple-gestation pregnancies
- pregnancies resulting from in vitro fertilization
- intrauterine fetal death
- having a family history of preeclampsia
- Women who have menstrual irregularity
- Women who have dyed their hair in the last 9 months
- Gestational diabetes mellitus
- Women receiving vanadium and/or magnesium treatment
Key Trial Info
Start Date :
June 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 30 2021
Estimated Enrollment :
210 Patients enrolled
Trial Details
Trial ID
NCT04387565
Start Date
June 1 2020
End Date
November 30 2021
Last Update
August 28 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cengiz Gokcek Women's and Child's hospital
Gaziantep, Turkey (Türkiye), 27010